Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Urotensin-II and UII-receptor expression and function in the rat adrenal cortex.

Albertin G, Casale V, Ziolkowska A, Spinazzi R, Malendowicz LK, Rossi GP, Nussdorfer GG.

Int J Mol Med. 2006 Jun;17(6):1111-5.

PMID:
16685423
2.

Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.

Spinazzi R, Albertin G, Nico B, Guidolin D, Di Liddo R, Rossi GP, Ribatti D, Nussdorfer GG.

Int J Mol Med. 2006 Dec;18(6):1107-12.

PMID:
17089015
3.

Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.

Hirose T, Takahashi K, Mori N, Nakayama T, Kikuya M, Ohkubo T, Kohzuki M, Totsune K, Imai Y.

Peptides. 2009 Jun;30(6):1124-9. doi: 10.1016/j.peptides.2009.02.009. Epub 2009 Feb 21.

PMID:
19463745
4.
5.

Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.

Prosser HC, Forster ME, Richards AM, Pemberton CJ.

Peptides. 2008 May;29(5):770-7. Epub 2007 Aug 21.

PMID:
17900760
6.

Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II.

Takahashi K, Totsune K, Murakami O, Arihara Z, Noshiro T, Hayashi Y, Shibahara S.

Peptides. 2003 Feb;24(2):301-6.

PMID:
12668216
7.

Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas.

Marco J, Egido EM, Hernández R, Silvestre RA.

Peptides. 2008 May;29(5):852-8. Epub 2007 Sep 4.

PMID:
17931748
8.

[Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].

Wang ZJ, Ding WH, Shi LB, Bu DF, Ren ZW, Tang CS.

Zhonghua Yi Xue Za Zhi. 2006 Jan 24;86(4):242-6. Chinese.

PMID:
16677503
9.

Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues.

Morimoto R, Satoh F, Murakami O, Totsune K, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K.

Peptides. 2008 May;29(5):873-80. Epub 2007 Jul 4.

PMID:
17686550
10.

Expression of prepro-ghrelin and related receptor genes in the rat adrenal gland and evidences that ghrelin exerts a potent stimulating effect on corticosterone secretion by cultured rat adrenocortical cells.

Rucinski M, Ziolkowska A, Tyczewska M, Malendowicz LK.

Peptides. 2009 Aug;30(8):1448-55. doi: 10.1016/j.peptides.2009.04.016. Epub 2009 May 4.

PMID:
19416745
11.
12.

The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.

Zeng ZP, Liu GQ, Li HZ, Fan XR, Liu DM, Tong AL, Zheng X, Liu C.

Ann N Y Acad Sci. 2006 Aug;1073:284-9.

PMID:
17102097
13.

Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.

Dubessy C, Cartier D, Lectez B, Bucharles C, Chartrel N, Montero-Hadjadje M, Bizet P, Chatenet D, Tostivint H, Scalbert E, Leprince J, Vaudry H, Jégou S, Lihrmann I.

J Neurochem. 2008 Oct;107(2):361-74. doi: 10.1111/j.1471-4159.2008.05624.x. Epub 2008 Aug 14.

14.

Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.

Dai HY, Guo XG, Ge ZM, Li ZH, Yu XJ, Tang MX, Zhang Y.

J Diabetes Complications. 2008 Mar-Apr;22(2):137-43. doi: 10.1016/j.jdiacomp.2006.10.008.

PMID:
18280445
15.

Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat.

Zhang Y, Li Y, Wei R, Wang Z, Bu D, Zhao J, Pang Y, Tang C.

Regul Pept. 2008 Nov 29;151(1-3):88-94. doi: 10.1016/j.regpep.2008.10.004. Epub 2008 Oct 14. Erratum in: Regul Pept. 2009 Apr 10;154(1-3):121.

PMID:
18955090
16.

Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.

Langham RG, Kelly DJ, Gow RM, Zhang Y, Dowling JK, Thomson NM, Gilbert RE.

Am J Kidney Dis. 2004 Nov;44(5):826-31.

PMID:
15492948
17.

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System.

Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Müller C, Müller C, Nayler O, Qiu C, Rey M, Scherz MW, Velker J, Weller T, Xi JF, Ziltener P.

J Pharmacol Exp Ther. 2004 Oct;311(1):204-12. Epub 2004 May 14.

18.

Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.

Zhang YG, Li YG, Liu BG, Wei RH, Wang DM, Tan XR, Bu DF, Pang YZ, Tang CS.

Acta Pharmacol Sin. 2007 Jan;28(1):36-43.

19.

A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker.

Rakowski E, Hassan GS, Dhanak D, Ohlstein EH, Douglas SA, Giaid A.

J Mol Cell Cardiol. 2005 Nov;39(5):785-91. Epub 2005 Sep 19.

PMID:
16171813
20.

Elevated expression of urotensin II and its receptor in diethylnitrosamine-mediated precancerous lesions in rat liver.

Wang H, Dong K, Xue X, Feng P, Wang X.

Peptides. 2011 Feb;32(2):382-7. doi: 10.1016/j.peptides.2010.10.032. Epub 2010 Nov 4.

PMID:
21056072
Items per page

Supplemental Content

Write to the Help Desk